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Abstract 
 
Modifications on histones or on DNA recruit proteins that regulate chromatin 
function. Here we use nucleosomes methylated on DNA and on histone H3 in 
an affinity assay, in conjunction with a SILAC-based proteomic analysis, to 
identify “cross-talk” between these two distinct classes of modification. Our 
analysis reveals proteins whose binding to nucleosomes is regulated by 
methylation of CpGs, H3K4, H3K9, and H3K27 or a combination thereof. We 
identify the Origin Recognition Complex (ORC), including LRWD1 as a 
subunit, to be a methylation-sensitive nucleosome interactor which is recruited 
cooperatively by DNA and histone methylation. Other interactors, such as the 
lysine demethylase Fbxl11/KDM2A, recognise nucleosomes methylated on 
histones but their recruitment is disrupted by DNA methylation. These data 
establish SILAC nucleosome affinity purifications (SNAP) as a tool for 
studying the dynamics between different chromatin modifications and provide 
a modification binding “profile” for proteins regulated by DNA and histone 
methylation. 
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Introduction 
 
Most of the genetic information of eukaryotic cells is stored in the nucleus in 
the form of a nucleoprotein complex termed chromatin. The basic unit of 
chromatin is the nucleosome which consists of 147 bp of DNA wrapped 
around an octamer made up of two copies each of the core histones H2A, 
H2B, H3 and H4 (Luger et al., 1997). Nucleosomes are arranged into higher 
order structures by additional proteins, including the linker histone H1, to form 
chromatin. Since chromatin serves as the primary substrate for all DNA-
related processes in the nucleus its structure and activity must be tightly 
controlled.  
Two key mechanisms known to regulate the functional state of chromatin in 
higher eukaryotes are the C5-methylation of DNA at cytosines within CpG 
dinucleotides and the post-translational modification of amino acids of histone 
proteins. Whereas DNA methylation is usually linked to silent chromatin and is 
present in most regions of the genome (Bernstein et al., 2007), the repertoire 
and the location of histone modifications is much more diverse with different 
modifications associated with different biological functions (Kouzarides, 2007). 
Most modifications can also be removed from chromatin, thus conferring 
flexibility in the regulation of its activity. Due to the large number of possible 
modifications and the enormous diversity that can be generated through 
combinatorial modifications, epigenetic information can be stored in chromatin 
modification patterns. Several chromatin-regulating factors have recently been 
identified that recognise methylated DNA or modified histone proteins. Such 
effector molecules use a range of different recognition domains such as 
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methyl-CpG-binding domains (MBD), zinc fingers (ZnF), chromo-domains, or 
plant homeodomains (PHD) in order to establish and orchestrate biological 
events (Sasai and Defossez, 2009; Taverna et al., 2007). However, most of 
these studies were conducted using isolated DNA or histone peptides and 
cannot recapitulate the situation found in chromatin. Considering the three-
dimensional organisation of chromatin in the nucleus, DNA methylation and 
histone modifications most likely act in a concerted manner by creating a 
“modification landscape” that must be interpreted by proteins able to 
recognise large molecular assemblies (Ruthenburg et al., 2007).  
In an effort to increase our understanding of how combinatorial modifications 
on chromatin might modulate its activity, we set out to identify factors that 
recognise methylated DNA and histones in the context of nucleosomes. We 
reasoned that using whole nucleosomes would enable us to find factors that 
integrate the folded nucleosomal structure with modifications on the DNA and 
on histones. Here we describe a SILAC nucleosome affinity purification 
(SNAP) approach for the identification of proteins that are influenced by CpG-
methylation and histone H3 K4, K9 or K27 methylation (or a combination 
thereof) in the context of a nucleosome. Our results reveal many proteins and 
complexes that can read the chromatin modification status. These results 
establish SNAP as a valuable approach in defining the chromatin  
“interactome”.  
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Results 
 
The SILAC Nucleosome Affinity Purification (SNAP)  
Proteins recognise modifications of chromatin in the context of a nucleosome. 
However, to date modification-interacting proteins have been identified using 
modified DNA or modified histone peptides as affinity columns. We set out to 
identify proteins that can sense the presence of DNA and histone methylation 
within the physiological background of a nucleosome. To this end we 
reconstituted recombinant nucleosomes containing combinations of CpG 
methylated DNA and histone H3 tri-methylated at lysine residues 4, 9, and 27  
(H3K4me3, H3K9me3 or H3K27me3). These modified nucleosomes were 
immobilised on beads and used to affinity purify interacting proteins from 
SILAC-labelled HeLa nuclear extracts (Figure 1A). Bound proteins regulated 
by the different modification patterns were identified by mass spectrometry 
(MS). 
The methylation of lysines in H3 was accomplished by native chemical ligation 
(Muir, 2003). An existing protocol (Shogren-Knaak et al., 2003) was adapted 
to develop an improved method that allows the purification of large quantities 
of recombinant tail-less human H3.1 (Figure 1B). This method employs the 
co-expression of Tobacco Etch Virus (TEV)-protease and a modified TEV-
cleavage site (Tolbert and Wong, 2002) to expose a cysteine in front of the 
histone core sequence in E. coli (Figure S1A). The tail-less H3.1 starting with 
a cysteine at position 32 was ligated to thioester peptides spanning the N-
terminus of histone H3.1 (residues 1-31) and containing the above-mentioned 
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methylated lysines (Figure S1B). The resulting full length modified H3.1 
proteins (Figure S1C) were subsequently refolded into histone octamers 
together with recombinant human histones H2A, H2B, and H4 (Figure 1C).  
As nucleosomal DNAs we used two biotinylated 185 bp DNA-fragments 
containing either the 601- or the 603-nucleosome positioning sequences 
(Lowary and Widom, 1998). Both DNAs have similar nucleosome-forming 
properties albeit with different sequences (Figure S1D) which allows us to test 
for sequence specificities of methyl-CpG interactors. The nucleosomal DNAs 
were treated with recombinant prokaryotic M.SssI DNA methyltransferase 
which mimics the methylation pattern found at CpG dinucleotides in eukaryotic 
genomic DNA (Figures S1E and S1F). Finally, nucleosomal core particles 
were reconstituted from the nucleosomal DNAs and octamers and 
immobilised on streptavidin beads via the biotinylated DNAs. All assembly 
reactions were quality controlled on native PAGE gels (Figure S1G).  
The immobilised modified nucleosomes were incubated in HeLaS3 nuclear 
extracts and probed for the binding of known modification-interacting factors 
to make sure that the nucleosomal templates were functional. Figure 1D 
shows that, as expected, PHF8, HP1α  and the Polycomb Repressive 
Complex 2 (PRC2) subunit SUZ12 (Bannister et al., 2001; Hansen et al., 
2008; Kleine-Kohlbrecher et al., 2010) specifically bind to H3K4me3-, 
H3K9me3-, and H3K27me3-modified nucleosomes, respectively. In addition, 
we did not detect any modification of the immobilised nucleosomal histones 
by modifying activities present in the nuclear extract (Figure S1H).  
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In order to identify proteins that bind to chromatin in a modification-dependent 
manner we utilised a SILAC pulldown approach that we have developed to 
identify interactors of histone modifications (Vermeulen et al., 2010). We 
simply replaced immobilised peptides with complete reconstituted modified 
nucleosomes (Figure 2A). All pulldowns were repeated in two experiments. In 
a “forward” experiment the unmodified nucleosomes were incubated with light 
(R0K0) extracts and the modified nucleosomes were incubated with heavy-
labelled (R10K8) extracts, as depicted in Figure 2A. In an independent 
“reverse” experiment the extracts were exchanged. Bound proteins were 
identified and quantified by high resolution MS for both pulldown experiments. 
A logarithmic (Log2) plot of the SILAC ratios H/L of the forward (X-axis) and 
reverse (Y-axis) experiments for each identified protein allows the unbiased 
identification of proteins that specifically bind to the modified or the unmodified 
nucleosomes. Proteins that preferentially bind to the modified nucleosomes 
show a high ratio H/L in the forward and a low ratio H/L in the reverse 
experiment and can, therefore, be identified as outliers in the bottom right 
quadrant. Proteins that are excluded by the modification have a low ratio H/L 
in the forward experiment and a high ratio H/L in the reverse experiment and 
appear in the top left quadrant. Background binders have a ratio H/L of around 
1:1 and cluster around the intersection of the X- and Y-axes. Outliers in the 
bottom left quadrant are contaminating proteins. Outliers in the top right 
quadrant are false positives. An enrichment/exclusion ratio of 1.5 in both 
directions generally identifies outliers outside of the background cluster. We 
consider a protein to be significantly regulated when it is enriched/excluded at 
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least 2-fold. Higher ratios H/L in the forward and lower ratios H/L in the 
reverse experiments indicate stronger binding whereas stronger exclusion is 
indicated by lower ratios H/L in the forward and higher ratios H/L in the 
reverse experiments.  
 
Proteins Identified by SNAP 
The SNAP approach was used to identify proteins that are recruited or 
excluded by DNA methylation, histone H3 methylation, or a combination of 
both (Figures 2B, 2C and S2). In Tables 1, 2 and Table S2 we summarise the 
proteins that display a regulation of at least 1.5 in both, the forward and 
reverse experiments, thus defining the proteins that are enriched or excluded 
by the modified nucleosomes. The complete MS analysis defining all 
interacting proteins in all pulldown reactions is summarised in Table S1.  
The dataset includes a number of proteins (about 20%) that are already 
known to bind methyl-DNA and methyl-H3 as well as many proteins whose 
regulation by modifications had not been previously defined. The presence of 
many known methyl-binding proteins validates our approach. The database 
provides a complex “profile” for the modulation of proteins by DNA and 
histone methylation that have the potential to recognise specific “chromatin 
landscapes”. Below we highlight several interactions with modified 
nucleosomes which exemplify the different modes of regulation we observe 
(summarised in Figure 2D and E). 
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Regulation by CpG Methylation 
Table 1 shows DNA- and nucleosome-binding proteins regulated by CpG 
methylation. The two different methylated DNAs were subjected to SNAP 
analysis either on their own (601me-DNA and 603me-DNA) or assembled into 
nucleosomes (601me-Nuc and 603me-Nuc). We identify several well 
characterised methyl-binding proteins such as MBD2 (Sasai and Defossez, 
2009) to be enriched on the 601me- and 603me-DNAs. MBD2 is enriched on 
both DNAs and exemplifies a form of methyl-CpG binding that is not sequence 
selective. In contrast, other proteins (e.g. ZNF295) display sequence 
specificity towards only one of the methylated DNAs, suggesting that they 
may recognise CpG methylation in a sequence specific manner.  
We also identify many proteins that preferentially recognise non-methylated 
DNA and are excluded by CpG-methylation. The most prominent example is 
the general RNA polymerase III transcription factor TFIIIC. All subunits of the 
TFIIIC complex show specific exclusion from the 603me-DNA (e.g. GTF3C5 
shown in Figure 2D) most likely because this DNA (unlike the 601me-DNA) 
contains two putative B-box elements (Figure S1D), sequences which are 
known TFIIIC binding sites. This defines a form of methyl-CpG-dependent 
exclusion that is sequence specific.  
CpG-methylation can have a distinct influence on protein binding when it is 
present within a nucleosomal background. Factors such as MeCP2 are 
specifically enriched on CpG-methylated DNA only in the context of a 
nucleosome but not on free DNA (Figure 2D). Other factors, such as 
L3MBTL3, show nucleosome-dependent exclusion by CpG methylation. 
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These two factors are influenced by DNA methylation regardless of DNA 
sequence. Several proteins, such as the DNA binding factor USF2 are 
specifically excluded only from 601me-nucleosomes. This is most likely due to 
an E-box motif in the 601-DNA (Figure S1D) which is recognised by USF2.  
One final example of the effect of nucleosomes on DNA binding proteins is 
demonstrated by the observation that many proteins such as TFIIIC bind free 
DNA but cannot recognise the DNA when it is assembled into nucleosomes. 
This is probably due to binding motifs (such as the B-box motif) being 
occluded by the histone octamer (Figure 2D and Table S2). This type of 
interaction may identify proteins that need nucleosome remodelling activities 
to bind their DNA element. Together these examples highlight the additional 
constraints forced on protein-DNA interactions by the histone octamer.  
 
Regulation by H3 Lysine Methylation 
Table 2 shows a summary of the proteins enriched or excluded by 
nucleosomes tri-methylated at H3K4, H3K9 or H3K27 in the presence or 
absence of DNA methylation. Tri-methylation of H3K4 is primarily associated 
with active promoters whereas tri-methyl H3K9 and H3K27 as well as methyl-
CpG are hallmarks of silenced regions of the genome (Kouzarides, 2007). 
We identify several known histone methyl-binding proteins in our screen such 
as the H3K4me3-interactor CHD1, the H3K9me3-binder UHRF1 and the 
H3K27me3-interacting polycomb group protein CBX8 (Hansen et al., 2008; 
Karagianni et al., 2008; Pray-Grant et al., 2005). In addition, a number of 
uncharacterised factors were identified. For example Spindlin1 binds strongly 
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to H3K4me3. Spindlin1 is a highly conserved protein consisting of three 
Spin/Ssty domains that have recently been shown to fold into Tudor-like 
domains (Zhao et al., 2007), motifs known to bind methyl-lysines on histone 
proteins. Most notably, we identify the origin recognition complex (Orc2, Orc3, 
Orc4, Orc5, and to a lesser extent Orc1) to be enriched on both, H3K9me3- 
and H3K27me3-modified nucleosomes. Since no binding was detected on 
H3K4me3-nucleosomes, the origin recognition complex (ORC) seems to 
specifically recognise heterochromatic modifications (Figure 2E). One protein, 
PHF14, and to a lesser extent HMG20A and HMG20B, are excluded by the 
H3K4me3-modification. Interestingly, these factors represent the only 
significant examples of proteins excluded from nucleosomes by methylation of 
histones, including methylation at H3K9 and H3K27.  
 
Crosstalk Between DNA and Histone Methylation 
The SNAP approach allows us to investigate cooperative effects between 
DNA methylation and histone modifications on the recruitment of proteins to 
chromatin. Analysis of our data reveals several examples of such a regulation 
(Figures 2E and 2F). We observe a cooperative stronger binding of UHRF1 to 
H3K9me3-modified nucleosomes in the presence of CpG-methylation. 
Similarly, the ORC complex (as shown for the Orc2 subunit) can recognise 
nucleosomes more effectively if CpG-methylation coincides with the 
repressive histone marks H3K9me3 or H3K27me3. This might explain its 
preferential localisation to heterochromatic regions in the nucleus (Pak et al., 
1997; Prasanth et al., 2004). In contrast, the H3K36 demethylase 
 12 
Fbxl11/KDM2A is enriched by H3K9-methylation but excluded by DNA 
methylation. Finally, the PRC2 complex is enriched on H3K27me3-
nucleosomes (and to a lesser extent on H3K9me3-nucleosomes) but 
incorporation of methyl-CpG DNA counteracts this recruitment as shown for 
the EED (Figure 2E) and the SUZ12 (Figure 2F) subunits. These findings 
demonstrate the ability of these factors to simultaneously monitor the 
methylation status of both histones and DNA on a single nucleosome. 
 
Identification of Complexes Regulated by Chromatin Modifications  
The proteins regulated by nucleosome modifications in the SNAP experiments 
were subjected to a cluster analysis in order to define common features of 
regulation. In this analysis the SILAC enrichment values are represented as a 
heat map in which proteins with similar interaction profiles group into clusters 
that may be indicative of protein complexes. Figure 3 shows that members of 
several known complexes cluster together in this analysis, including the 
BCOR and the NuRD corepressor complexes (Gearhart et al., 2006; Le 
Guezennec et al., 2006).  
 
Identification of LRWD1 as an ORC-interacting Protein 
The cluster analysis also identifies the ORC complex based on the similar 
interaction profiles of the ORC subunits. Interestingly an uncharacterised 
protein termed LRWD1 closely associates with the ORC cluster (see also 
Figures 2B, C and S2G, H) suggesting that this protein may be a component 
of ORC. To test this hypothesis we raised an antibody against LRWD1 (Figure 
 13 
S3A) and used it to probe for co-localisation with the ORC complex by 
immunofluorescence (IF) staining of MCF7 cells. Figure 4A indicates that 
LRWD1 co-localises with the ORC complex at a subset of nuclear foci marked 
by strong staining with an antibody against the Orc2 subunit. As previously 
shown for Orc2 (Prasanth et al., 2004), these foci often co-localise with HP1α, 
a marker for H3K9me3-containing heterochromatin (Figure S3B). In addition, 
endogenous LRWD1 and Orc2 can be co-immunoprecipitated from extracts 
prepared from MCF7 and HelaS3 cells (Figures 4B and S3C). We further 
expressed various truncated variants of FLAG-tagged LRWD1 in 293T cells 
and immunoprecipitated them using an anti-FLAG antibody. The co-
immunoprecipitation of Orc1 and Orc2 indicates that LRWD1 interacts with 
ORC via its WD40 domain (Figures 4C and D and S3D). Similar to Orc3 
(Prasanth et al., 2004), expression of LRWD1 depends on Orc2 since 
reducing Orc2 expression in MCF7 cells by siRNA treatment also reduces 
LRWD1 protein levels (Figure 4E) without perturbing its transcription (data not 
shown). These experiments establish LRWD1 as an ORC-component and 
demonstrate the potential of the modification interaction profiling for the 
identification of protein complex subunits. 
 
Recognition of Nucleosome Modification Status by Fbxl11/KDM2A 
To provide independent validation of the SNAP approach we investigated in 
more detail the modulation of binding of Fbxl11/KDM2A by DNA and histone 
methylation. This enzyme is a JmjC-domain protein that demethylates lysine 
36 on histone H3 (Tsukada et al., 2006). Our data show that KDM2A is 
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enriched on H3K9me3-modified nucleosomes but its recruitment is disrupted 
by CpG-methylation on either free or nucleosomal DNA (Figure 2E).  
KDM2A has several described isoforms and in our initial SNAP experiments 
some identified KDM2A peptides showed a markedly lower enrichment than 
others. The H3K9me3-nucleosome SILAC pulldown was repeated to assign 
the identified peptides to gel bands covering different molecular weights. Most 
peptides were detected in a band corresponding to a molecular weight of 60-
75 kDa and mapped to the C-terminal half of KDM2A (Figure S4A and B). 
Probing for the binding of KDM2A to modified nucleosomes by immunoblot 
also showed enrichment of a lower molecular weight isoform (Figures 2F and 
S4C). Immunoprecipitating KDM2A from nuclear extracts confirmed the 
presence of this isoform (Figure S4D). This variant corresponds to the 
recently described 70 kDa isoform KDM2ASF that is transcribed from an 
alternative promoter and spans the C-terminal half of KDM2A from position 
543 (Tanaka et al., 2010).  
We next sought to verify the recruitment of KDM2A to the H3K9me3-
modification seen by SNAP in a different biochemical assay. To this end, 
various methylated and unmethylated nucleosomes or histone H3 peptides 
were used to isolate FLAG-tagged full length KDM2A from transfected 293T 
cell extracts. The SILAC experiments indicated a moderate enrichment of 
KDM2A on H3K9me3-nucleosomes (Figure 2E). However, we could not 
detect substantial binding to either H3K9me3-modified nucleosomes (Figure 
5A, lane 5) or peptides (Figure 5A, lane 8) with the over-expressed protein. 
This result suggested the possibility that KDM2A may need a second factor in 
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order to recognise H3K9me3. A recent study reporting the interaction of 
KDM2A with all HP1 isoforms (Frescas et al., 2008) prompted us to test 
whether the binding was mediated by HP1. Indeed, addition of purified HP1α 
to the pulldown reactions strongly stimulated the association of KDM2A to 
H3K9me3-nucleosomes (Figure 5A, lane 13). Using HP1α, β, and γ showed 
that the interaction could be mediated by all HP1 isoforms (Figure 5B).  
We next verified the disruptive effect of DNA methylation seen in the SNAP 
experiments. KDM2A harbours a DNA-binding module consisting of a CXXC-
type zinc finger domain that was recently demonstrated to bind unmethylated 
CpG residues and to be sensitive to DNA methylation (Blackledge et al., 
2010). When FLAG-tagged KDM2A was isolated from extracts with 
immobilised 601-DNA (Figure S4E) binding was abolished by CpG 
methylation as expected. We also sought to establish whether the recruitment 
of KDM2A to H3K9me3-nucleosomes in the presence of HP1 could be 
disrupted by DNA methylation. Lane 14 in Figure 5A clearly shows that 
KDM2A cannot recognise H3K9me3-nucleosomes when the DNA is 
methylated. The simultaneous recognition of DNA and HP1 leads to a 
stronger association with nucleosomes. This is indicated by a more effective 
recruitment of KDM2A to H3K9me3-nucleosomes compared to H3K9me3-
modified peptides in the presence of HP1 (compare lanes 13 and 16 in Figure 
5A).  
To confirm that the recruitment of KDM2A to nucleosomes through HP1 also 
occurs in a physiological context, we investigated whether the recently 
reported localisation of KDM2A to ribosomal RNA genes (rDNA) in MCF7 cells 
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(Tanaka et al., 2010) is dependent on HP1. Indeed, down-regulation of 
HP1α by siRNA results in a specific decrease of HP1α and KDM2A binding, 
as assessed by chromatin immunoprecipitation (ChIP) analysis (Figure 5C 
and D). 
Together these experiments confirm the observations made using SNAP and 
show that KDM2A recognises H3K9me3 via HP1 and that an additional 
interaction component is conferred by its recognition of DNA, which is 
sensitive to the state of methylation.  
 
Discussion 
Proteins are localised on chromatin depending on a complex set of cues 
derived from the recognition of histones and DNA in a modified or unmodified 
form. Here we present an approach (SNAP) that allows the identification of 
proteins that recognise distinct chromatin modification patterns. The SNAP 
method employs modified recombinant nucleosomes to isolate proteins from 
SILAC-labelled nuclear extracts and to identify them by mass spectrometry. In 
this study we have used nucleosomes containing a combination of 
methylation events on DNA (CpG) and histone H3 (K4, K9, and K27). It is 
apparent from our results that proteins recognising methylated nucleosomes 
can be influenced by (a) the DNA sequence (in a modified and unmodified 
form), (b) the configuration of the histone octamer, and (c) the precise 
combination of histone and DNA modifications.  Below we discuss these 
modes of engagement.  
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(a) Recognition of DNA. The use of two distinct DNA sequences (601 or 
603) in our SNAP experiments has identified proteins that recognise methyl-
CpGs in a sequence specific way (e.g. ZNF295) as well as proteins that are 
not sequence selective (e.g. MBD2). This suggests that some proteins may 
have a promiscuous methyl-DNA recognition domain (i.e. recognising 
methylated CpG dinucleotides regardless of the surrounding DNA sequence) 
whereas others require a specific motif surrounding the methylated CpG site. 
Analysis of factors recognising CpG methylation for the presence of known 
domains identifies a striking number of zinc finger-containing proteins (Table 
S2). Our data indicate that around 50% of proteins binding to methyl-CpG and 
20% of proteins excluded from methylated DNA and nucleosomes harbour a 
zinc finger domain, a motif already known to have methyl-CpG-binding 
potential (Sasai and Defossez, 2009). Interestingly, the second most 
prevalent domain in methyl-CpG-binding proteins (20%) is a homeobox (e.g. 
in HOMEZ, PKNOX1 and ZHX proteins). Homeoboxes are known DNA-
binding domains but have not previously been demonstrated to bind methyl-
CpG. These data raise the possibility that homeoboxes may possess a 
methyl-CpG recognition function.  
(b) Influence of nucleosomes. When methylated 601- or 603-DNA is 
incorporated into nucleosomes the histone octamer appears to have an effect 
on the binding of certain proteins. The TFIIIC complex cannot bind a B-box 
effectively in the presence of an octamer, suggesting the need for remodelling 
activities for full access. The methyl-CpG-binding protein MeCP2 is seen to 
bind DNA-methylated nucleosomes, but showed no binding to methyl-DNA in 
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the absence of a histone octamer. The USF2 transcription factor is excluded 
from its binding site in the 601-DNA more strongly in the presence of histone 
octamers. These examples indicate that the histone octamer may have a 
steric effect on the DNA-binding of such factors or that these factors contain 
additional contact points with histones which results in an increased affinity to 
nucleosomes compared to free DNA.  
(c) Regulation by a combination of DNA and histone methylation. 
Proteins are able to associate with nucleosomes depending on the precise 
status of DNA and histone methylation. UHRF1, which binds cooperatively to 
methyl-DNA and H3K9me3, may represent a class of proteins that have an 
intrinsic capacity to recognise both modifications directly since it contains a 
SRA domain that binds methylated DNA and a tandem Tudor and a PHD 
domain that can bind methylated H3K9 (Hashimoto et al., 2009). In the case 
of protein complexes the recognition of each modification may reside on 
separate subunits. We identified two protein complexes, ORC and PRC2, that 
are influenced by both types of modification in opposite ways. The ORC 
complex, including the LRWD1 protein, recognises H3K9- and H3K27-
methylation in a cooperative manner with DNA methylation. This may allow for 
a stronger interaction of ORC with heterochromatic regions (Pak et al., 1997; 
Prasanth et al., 2004). The PRC2 complex, which recognises H3K27-
methylation, is negatively regulated by DNA-methylation. This may enable this 
transcriptional repressor to associate preferentially with a specific chromatin 
state that is not silenced completely and can respond to external stimuli, such 
as poised genes. Finally, the KDM2A histone H3K36-demethylase can 
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recognise H3K9me3 indirectly via its association with HP1 and recruitment is 
blocked when DNA is methylated. This disruptive effect would allow the 
demethylase to distinguish between distinct chromatin landscapes: it will 
recognise silenced genes that are marked by H3K9-methylation and HP1 but 
it will not dock on heterochromatic regions that carry both H3K9me3- and 
DNA-methylation. Together, these examples provide evidence that proteins 
can monitor the methylation state of both, histones and DNA, in order to 
discriminate between distinct states of repressed chromatin. 
 
SNAP as a Tool for Studying Chromatin Modification Crosstalk 
SNAP has several advantages over the current approaches using peptides 
and oligonucleotides to identify chromatin-binding factors. One advantage is 
that nucleosomes provide a more physiological substrate. Proteins may have 
a number of contact points to chromatin (histone tails, histone core, DNA) and 
may recognise more than one histone at a time. As a result of this multiplicity 
of possible interactions, SNAP will allow the identification of proteins whose 
affinity may be too weak to be selected for by the current methods. Our results 
clearly identify proteins, such as KDM2A, whose binding depends on such a 
physiological nucleosomal context. A second powerful advantage of SNAP is 
that it allows the identification of proteins that recognise multiple independent 
modifications on chromatin. In this study, we have analysed histone 
modifications in combination with DNA methylation. But it is equally possible 
to monitor the binding of proteins to combinations of histone modifications 
either on the same histone or on different histones or to use multiple 
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nucleosomes. The SNAP approach is also suitable for modified histones 
generated using methyl-lysine analogues (Simon et al., 2007). But since 
binding affinities might be crucial for the identification of interacting proteins 
natural modified amino acids might be more desirable. In this regard, recent 
successful attempts to genetically install modified amino acids in recombinant 
histones are very promising (Neumann et al., 2009; Nguyen et al., 2009). In 
Summary, our findings demonstrate that chromatin modification-binding 
proteins can recognise distinct modification patterns in a chromatin 
landscape. The SNAP approach is therefore a valuable tool for studying the 
mechanisms by which epigenetic information encoded in chromatin 
modifications can be interpreted by proteins.  
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Experimental Procedures 
 
Extract Preparation and Immunoprecipitation 
HeLa S3 cells were grown in suspension in RPMI 1640 medium containing 
5% FBS and normal arginine and lysine or 5% dialysed FBS and heavy 
arginine-13C6, 15N4 and lysine-13C6, 15N2 (Isotec). Cells were harvested at a 
density of 0.5-0.8x106 cells/ml and nuclear extracts were essentially prepared 
as described (Dignam et al., 1983). For both SILAC extracts three 
independent nuclear extracts were prepared and pooled to yield an “average” 
extract that compensates for differences in each individual preparation. 293T 
and MFC7 cells were grown in DMEM medium supplemented with 10% FBS. 
293T cells were transfected using a calcium phosphate protocol. Whole cell 
extracts were prepared ~36h after transfection by rotating the cells in 
extraction buffer (20 mM Hepes pH7.5; 300 mM NaCl; 1 mM EDTA; 20% 
Glycerol; 0.5% NP40; 1 mM DTT and complete protease inhibitors [Roche]) 
for 1 h at 4°C. HeLa S3 nuclear extracts and 293T or MCF7 whole cell 
extracts were snap frozen and stored in aliquots at -80°C. For co-
immunoprecipitations, extracts were prepared without DTT and diluted 1:1 
with 20 mM Hepes pH7.5; 1 mM EDTA; 20% Glycerol containing complete 
protease inhibitors. Extracts were pre-cleared and proteins 
immunoprecipitated with typically 5 µg of antibody and Protein-G Sepharose 
(GE Healthcare) or 20 µl anti-FLAG M2 agarose (Sigma).  
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Chromatin Immunoprecipitation and Immunofluorescence 
For ChIPs, MCF7 cells were reverse-transfected with siRNAs against HP1α or 
negative control siRNA using Lipofectamine™ RNAiMAX (Invitrogen) 
according to the manufacturerʼs protocol. 48h after transfection, cells were 
washed twice with PBS, fixed with 1% formaldehyde (Sigma) in PBS at room 
temperature for 10 min and quenched with 125 mM Glycine for 5 min. After 
three washes with 10 ml of cold PBS cells were harvested in cold PBS 
supplemented with Complete Protease Inhibitor cocktail by scraping. Pellets 
from two 10 cm dishes were suspended in 1.6 ml of RIPA buffer (50 mM Tris-
HCl, pH 8; 150 mM NaCl; 2mM EDTA; 1% NP-40; 0.5% Sodium 
Deoxycholate; 0.1% SDS supplemented with EDTA-free complete protease 
inhibitors), sonicated in 15 ml conical tubes three times 10 minutes at High, 30 
sec ON/OFF cycles in a cooled Bioruptor® (Diagenode) and cleared by 
centrifugation for 15 min at 13,000 rpm. ChIPs were then performed as 
described (Xhemalce and Kouzarides, 2010). The PCR analysis was 
performed on a StepOnePlus™ Real-Time PCR System using Fast SYBR® 
Green (Applied Biosystems). For IFs, MCF7 cells were grown in slide flasks, 
washed with PBS, treated for 5 min on ice with CSK buffer (10mM PIPES 
pH6.8, 100mM NaCl, 300mM sucrose, 3mM MgCl2, 1mM EGTA and 0.5% 
Triton), washed again with PBS and fixed with 5% Formalin solution (Sigma) 
in PBS/2% sucrose. The fixed cells were incubated O/N at 4°C with 0.5µg/ml 
of each primary antibody, and for 1 h at RT with DAPI and the secondary 
antibodies. Images were acquired with an Olympus FV1000 Upright confocal 
microscope and processed using Adobe Photoshop® CS software. 
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Protein Expression and Purification  
Recombinant histone proteins were expressed in E. coli BL21(DE3)/RIL cells 
from pET21b(+) (Novagen) vectors and purified by denaturing gelfiltration and 
ion exchange chromatography essentially as described (Dyer et al., 2004). 
Truncated H3.1Δ1-31T32C protein was generated in vivo by expressing a 
H3.1Δ1-31T32C precursor in the presence of TEV-protease. For this purpose 
E. coli cells harbouring the pET28a(+)-AraC-PBAD-His6TEV/pro-H3.1Δ1-
31T32C plasmid were grown in LB medium containing 0.25% L-arabinose to 
keep TEV-protease induced. At an OD600 of 0.6 the expression of pro-
hH3.1Δ1-31T32C was induced for 3 h at 37°C with 50 µM IPTG. TEV-
protease processes the precursor histone H3.1 into tail-less H3.1Δ1-31T32C. 
The insoluble protein was extracted from inclusion bodies with solubilisation 
buffer (20 mM Tris pH 7.5; 7 M Guanidine HCl; 100 mM DTT) for 1 h at RT 
and passed over a Sephacryl S200 gel-filtration column (GE Healthcare) in 
SAU-200 (20 mM NaAcetate pH5.2; 7 M Urea; 200 mM NaCl; 1 mM EDTA) 
without any reducing agents. Positive fractions were directly loaded onto a 
reversed phase ResourceRPC column (GE Healthcare) and eluted with a 
gradient of 0% - 65% B (A: 0.1% TFA in water, B: 90% Acetonitrile; 0.1% 
TFA) over 20 column volumes. Fractions containing pure H3.1Δ1-31T32C 
were pooled and lyophilised. All histone proteins were stored lyophilised at -
80°C. Recombinant HP1 GST-fusion proteins were expressed in E. coli 
BL21(DE3)/RIL cells and purified by glutathione sepharose (GE Healthcare) 
chromatography. HP1 proteins were cleaved off the beads with biotinylated 
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thrombin (Novagen). After removal of thrombin with streptavidin sepharose 
HP1 proteins were dialysed into TBS/10% glycerol, snap frozen and stored at 
-80°C. 
 
Preparation of Modified Histones and Nucleosomal DNAs 
For native chemical ligations lyophilised modified H3.1 1-31 thioester peptide 
(Almac) was incubated at a concentration of 0.56 mg/ml (~0.167 mM) with 
truncated H3.1Δ1-31T32C protein at 4 mg/ml (~0.333 mM) and thiophenol at 
2% (v/v) in ligation buffer (6 M Guanidine HCl; 200 mM KPO4 pH7.9). The 
cloudy mixture was left shaking vigorously at RT for 24 h. The reaction was 
stopped by adding DTT to a final concentration of 100 mM, dialysed three 
times against SAU-200 buffer containing 5 mM 2-Mercaptoethanol, and then 
loaded onto a Hi-Trap SP HP column (GE-Healthcare). The ligated Histone 
H3 was eluted with a linear gradient from SAU-200 to SAU-600 buffer (20 mM 
NaAcetate pH5.2; 7 M Urea; 600 mM NaCl; 1 mM EDTA; 5 mM 2-
Mercaptoethanol). Positive fractions were pooled, diluted 3-fold in SAU-0 
buffer (20 mM NaAcetate pH5.2; 7 M Urea; 1 mM EDTA; 5 mM 2-
Mercaptoethanol) to reduce the NaCl concentration and reloaded onto the 
column. Three rounds of purification were needed to yield sufficiently pure 
ligated histone. Following ion exchange purification, the ligated histone was 
dialysed against water containing 1 mM DTT, lyophilised and stored at -80°C. 
Nucleosomal 601- or 603-DNAs were excised from purified plasmid DNAs 
(Plasmid Giga Kit, Qiagen) by digestion with EcoRV and separated from the 
vector by PEG precipitation as described (Dyer et al., 2004). For end-
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biotinylation the DNA was further digested with EcoRI and the overhangs filled 
in with biotin-11-dUTP (Yorkshire Bioscience) using Klenow (3ʼ->5ʼ exo-) 
polymerase (NEB). Nucleosomal biotinylated DNAs were then separated by 
PEG precipitation or further methylated with M.SssI CpG Methyltransferase 
(NEB) and then PEG-precipitated to remove small cleavage products. 
 
Reconstitution of Nucleosomes and Nucleosome Pulldowns 
Octamers were refolded from purified histones and assembled into 
nucleosomes with biotinylated nucleosomal DNAs by salt deposition as 
described (Dyer et al., 2004). Optimal reconstitution conditions were 
determined by titration and then kept constant for all nucleosome assembly 
reactions. Nucleosomes were checked on 5% native PAGE gels. For SILAC 
pulldowns, nucleosomes corresponding to 12.5 µg of octamer were 
immobilised on 75 µl Dynabeads Streptavidin MyOne T1 (Invitrogen) in the 
final reconstitution buffer (10 mM Tris pH 7.5; 250 mM KCl; 1 mM EDTA; 1 
mM DTT; supplemented with 0.1% NP40) and then rotated with 0.5 mg HeLa 
S3 nuclear extract in 1 ml of binding buffer (20 mM Hepes pH7.9; 150 mM 
NaCl; 0.2 mM EDTA; 20% Glycerol; 0.1% NP40; 1 mM DTT and complete 
protease inhibitors) for 4 h at 4°C. After five washes with 1 ml of binding buffer 
the beads from both SILAC pulldowns were pooled and bound proteins were 
eluted in sample buffer and analysed on 4-12% gradient gels by colloidal blue 
staining (NuPAGE/NOVEX, Invitrogen). For DNA and peptide pulldowns 
streptavidin coated magnetic beads were saturated with either biotinylated 
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601-DNA or H3 peptides (residues 1-21) and then used as described for the 
nucleosome beads. 
 
Mass Spectrometry of Proteins and Computational Analyses 
Nucleosome-bound proteins resolved on SDS-PAGE gels were subjected to 
in-gel trypsin digestion as described (Vermeulen et al., 2010). Peptide 
identification experiments were performed using an EASY nLC system 
(Proxeon) connected online to an LTQ-FT Ultra mass spectrometer (Thermo 
Fisher, Germany). Tryptic peptide mixtures were loaded onto a 15-cm-long 
75-μm ID column packed in-house with 3-μm C18-AQUA-Pur Reprosil 
reversed-phase beads (Dr. Maisch GmbH) and eluted using a 2-h linear 
gradient from 8 to 40% acetonitrile. The separated peptides were 
electrosprayed directly into the mass spectrometer, which was operated in the 
data-dependent mode to automatically switch between MS and MS2. Intact 
peptide spectra were acquired with 100,000 resolution in the FT cell while 
acquiring up to five tandem mass spectra in the LTQ part of the instrument. 
Proteins were identified and quantified by analysing the raw data files using 
the MaxQuant software, version 1.0.12.5, in combination with the Mascot 
search engine (Matrix Science), essentially as described (Vicent et al., 2009). 
The raw data from all forward and reverse pulldowns were processed together 
and filtered such that a protein was only accepted when it was quantified with 
at least two peptides, both in the forward and the reverse pulldown. Results 
from the pulldowns were visualised using the open source software package 
R. For the cluster analysis, the log2 ratio between the forward and reverse 
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SILAC values (ratio H/L) of each protein was calculated. These data were 
clustered to identify related clades of proteins. Clustering was performed in R 
using the hopach package (van der Laan and Pollard, 2003). The distance 
between pairwise log2 ratio values was calculated using the absolute 
uncentered correlation distance, and agglomerative hierarchical clustering 
using complete linkage was performed. 
 
Deposition of MS-related Data 
The MS raw data files for nucleosome pulldowns can be accessed via 
TRANCHE (https://proteomecommons.org/) under the name “SILAC 
Nucleosome Affinity Purification”. 
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Figure Legends 
 
Figure 1. Preparation of Reconstituted Modified Nucleosomes 
(A) Experimental strategy for the preparation of immobilised and modified 
nucleosomes for pulldown studies. (B) The native chemical ligation strategy 
for generating post-translationally modified histone H3.1. We bacterially 
express an IPTG-inducible truncated histone precursor containing a modified 
TEV-cleavage site (ENLYFQ↓C) followed by the core sequence of histone 
H3.1 starting from glycine 33. The plasmid also contains TEV-protease under 
the control of the AraC/PBAD-promoter. TEV-protease accepts a cysteine 
instead of glycine or serine as the P1ʼ-residue of its recognition site, and upon 
arabinose induction it processes the precursor histone into the truncated form 
(H3.1Δ1-31 T32C) which is purified and ligated to modified thioester peptides 
spanning the N-terminal residues 1 to 31 of histone H3.1. All ligated histones 
contain the desired modification and a T32C mutation. (C) Summary of the 
modified histone octamers. The upper panel shows 1 µg of each octamer 
separated by SDS-PAGE and stained with Coomassie. For the bottom panel 
octamers were dot blotted on PVDF-membranes and probed with 
modification-specific antibodies as indicated. The anti-H3K27me3 antibody 
shows slight cross-reactivity with H3K4me3 and H3K9me3. (D) Functional test 
of the nucleosome affinity matrix. R10K8-labelled nuclear extract was 
incubated with immobilised modified nucleosomes as indicated. Binding of 
PHF8, HP1α, and SUZ12 was detected by immunoblot. Equal loading was 
confirmed by silver and Coomassie staining. Modification of histone H3 was 
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verified by immunoblot against H3 tri-methyl lysine marks. All three antibodies 
show slight cross-reactivity with the other histone marks. See also Figure S1. 
 
Figure 2. Identification of Nucleosome-interacting Proteins Regulated by 
DNA and Histone Methylation using SNAP 
(A) Experimental design of the SILAC nucleosome affinity purifications. 
Nuclear extracts are prepared from HeLaS3 cells grown in conventional “light” 
medium or medium containing stable isotope-labelled “heavy” amino acids. 
The resulting “light”- and “heavy”-labelled proteins can be distinguished and 
quantified by MS. Immobilised unmodified or modified nucleosomes are 
separately incubated with light or heavy extracts, respectively. Both pulldown 
reactions are pooled and eluted proteins are separated by SDS-PAGE. After 
in-gel trypsin digestion, peptides are analysed by high resolution MS. (B) 
Results of SNAP performed with H3K9me3-modified nucleosomes containing 
unmethylated 601-DNA. Shown are the Log2-values of the SILAC ratios (ratio 
H/L) of each identified protein for the forward (X-axis) and the reverse (Y-axis) 
experiments. The identities of several interacting proteins are indicated. 
Subunits of the MBD2/NuRD-complex are labelled in orange. (C) Results of 
SNAP performed with H3K9me3-modified nucleosomes containing CpG-
methylated 601-DNA.  For additional SNAP results see Figure S2 and Table 
S1. (D) Differential recognition of nucleosomes. The graphs show the forward 
SILAC enrichment values (Ratio H/L forward) of MeCP2, L3MBTL3, USF2, 
and the TFIIIC subunit GTF3C5 on CpG-methylated DNAs and modified 
nucleosomes. Binding to the modified nucleosomes or DNAs is indicated in 
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red, exclusion is indicated in blue. If proteins were not detected (n.d.) no value 
is assigned. (E) Crosstalk between DNA and histone methylation. The graphs 
show the SILAC enrichment values of the proteins KDM2A, UHRF1, the 
PRC2 subunit EED, and the ORC subunit Orc2 as described in (D). (F) 
Immobilised modified nucleosomes were incubated with an independently 
prepared R0K0-nuclear extract as indicated. Binding of KDM2A, UHRF1, Orc2, 
and the PRC2 subunit SUZ12 was detected by immunoblot. Equal loading 
and modification of histone H3 were verified as in Figure 1D. The asterisk 
marks a cross-reactive band recognised by the KDM2A antibody. 
 
Figure 3. Interaction Profiles of Chromatin Modification-binding Proteins 
Agglomerative hierarchical clustering was performed on the SILAC 
enrichment values of proteins regulated by DNA and histone methylation to 
identify proteins with related binding profiles. This analysis includes proteins 
based on an enrichment/exclusion of at least 1.5 fold in both directions in one 
of the nucleosome pulldown experiments and excludes factors that were 
found solely in the DNA pulldowns. Log2(ratiofor/ratiorev) is the log2 ratio 
between the SILAC values (ratio H/L) of the forward and reverse experiments. 
Enrichment by modifications is indicated in red, exclusion is indicated in blue. 
Grey bars indicate if proteins were not detected (n.d.) in particular 
experiments. These incidences were not included in the cluster analysis. 
Clusters of several known protein complexes and their respective subunits are 
indicated on the right. For values see Table S2. 
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Figure 4. LRWD1 Interacts with the Origin Recognition Complex 
(A) LRWD1 co-localises with Orc2. IF staining of MCF7 cells with LWRD1 
(2527) and Orc2 antibodies following pre-extraction shows co-localisation at 
distinct nuclear foci. (B) LRWD1 and ORC co-immunoprecipitate. LRWD1 and 
Orc2 were immunoprecipitated from MCF7 whole cell extracts and interacting 
proteins were detected by immunoblot as indicated. LRWD1 was 
immunoprecipitated using anti-LRWD1 (A301-867A) and detected using anti-
LRWD1 (2527) antibodies. Anti-FLAG and anti-GFP antibodies were used as 
IgG negative controls. Asterisks mark bands derived from antibody heavy 
chains. (C) FLAG-tagged full length and truncated versions of LRWD1 were 
over-expressed in 293T cells and immunoprecipitated using an anti-FLAG 
antibody. 1 % of the input and 10% of the IP were separated by SDS-PAGE 
and Orc1, Orc2 and the FLAG fusions were detected by immunoblot. The 
asterisks mark bands derived from the anti-FLAG IP antibody. (D) Identities of 
the LRWD1 truncation constructs. Only deletions containing the WD40 
repeats interact with ORC. (E) LRWD1 expression is Orc2-dependent. 
Expression levels of LRWD1 and ORC proteins in MCF7 cells were detected 
by immunoblot after transfection with siRNAs against LRWD1 and Orc2 as 
indicated. Cells were reverse-transfected twice, 56 h and 28h before 
harvesting. GAPDH serves as a loading control. The asterisk marks a cross-
reactive band detected by the anti-LRWD1 (2527) antibody. See also Figure 
S3. 
 
 
 36 
 
Figure 5. Fbxl11/KDM2A Integrates DNA Methylation and H3K9me3-
modification Signals on Nucleosomes  
(A) In vitro binding of KDM2A to modified nucleosomes. Whole cell extracts 
prepared from transiently transfected 293T cells over-expressing FLAG-
tagged KDM2A were incubated with immobilised modified nucleosomes or 
modified H3-peptides as indicated. Binding reactions were supplemented with 
recombinant purified HP1α or GST as a control. Binding was detected by 
immunoblot against the FLAG-tag or HP1α. Equal loading of the nucleosomes 
and peptides, and modification of histone H3 were verified as in Figure 1D. (B) 
KDM2A binding to H3K9me3-Nucleosomes is mediated by HP1α, β, and γ. 
Unmodified or H3K9me3-modified nucleosomes were immobilised on 
streptavidin beads and incubated with 293T whole cell extracts over-
expressing FLAG-tagged KDM2A. Pulldown reactions were supplemented 
with recombinant purified HP1α, β, or γ or GST as indicated. Binding of 
KDM2A was detected by immunoblot against the FLAG-tag. (C) Recruitment 
of KDM2A to the rDNA locus is augmented by HP1α. MCF7 cells were 
transfected with HP1α-specific siRNAs and analysed for the enrichment of the 
H13 region of the rDNA locus by ChIP using antibodies against KDM2A, 
HP1α and histone H3K9me3. Shown are the mean ± SD of the signals 
normalised to input of three independent experiments. KDM2A shows only 
little enrichment at the GAPDH locus. (D) Analysis of KDM2A and HP1α 
expression in siRNA-treated MCF7 cells by immunoblot. GAPDH serves as 
loading control. See also Figure S4. 
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Supplemental Figure Legends 
 
Figure S1. Native Chemical Ligation of Post-translationally Modified 
Histones and Preparation of CpG-methylated DNA and Nucleosomes, 
related to Figure 1 
(A) Co-expression of a TEV-cleavable H3 precursor histone with TEV 
protease in E. coli leads to processing into a truncated histone H3.1 
competent for native chemical ligations. Extracts from E. coli cells induced for 
expression of the histone H3 precursor with and without co-expression of 
TEV-protease were separated by SDS-PAGE and either stained for proteins 
with Coomassie or probed with an anti-His6-tag antibody to detect His6-TEV-
protease. The processing of the precursor into the truncated histone H3.1 
carrying a cysteine instead of a threonine in position 32 is indicated. (B) 
Native chemical ligation of histone H3. Truncated histone H3.1Δ1-31 T32C 
was incubated with an unmodified H3 N-terminal thioester peptide under 
denaturing conditions at a molar ratio of histone:peptide of ~2:1 and full length 
ligated H3 subsequently purified by ion-exchange chromatography. Shown 
are the truncated H3 before ligation, the final ligation product and the purified 
ligated H3. Ligation of the unmodified peptide is shown as a representative 
example. All other ligations and purifications were equally efficient. (C) 
Summary of the ligated and modified histone H3 proteins used in this study. 1 
µg of each histone H3 was separated by SDS-PAGE and stained with 
Coomassie. Purified recombinant wild-type (rec. WT) histone H3.1 is shown 
as a comparison. (D) Sequences of the 601- and 603-DNAs used in this 
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study. The core nucleosome positioning sequences are indicated in bold 
letters. CpG-dinucleotides that are methylated in the 601me- and 603me-DNA 
are highlighted in red. An E-box sequence in the 601-DNA and two putative B-
box sequences in the 603-DNA are underlined. The DNA is biotinylated at one 
end to allow immobilisation on a streptavidin matrix. (E) Outline of the strategy 
for the large-scale preparation of biotinylated and CpG-methylated 
nucleosomal 601-DNA. The 601-fragment is cleaved from a plasmid 
harbouring multiple tandem repeats of the sequence flanked by EcoR V 
restriction sites and separated from the vector DNA by PEG-precipitation. The 
fragment is cleaved with EcoR I at an internal EcoR I restriction site which is 
then filled in with biotin-dUTP using Klenow polymerase. CpG dinucleodtides 
are methylated using M.SssI enzyme and the final nucleosomal DNA is 
separated by a second PEG-precipitation. The 603-DNA was prepared in the 
same way. (F) Verification of CpG methylation. A PAGE gel of the digestion of 
unmethylated and CpG-methylated 601-DNA with methylation-sensitive 
restriction enzymes (BstU I and Not I) shows complete methylation of CpG 
sites. The black arrowhead indicates the undigested 601-DNA and grey 
arrowheads the positions of expected digestion fragments. The complete CpG 
methylation of the 603me-DNA was verified in the same way (Data not shown). 
(G) Verification of nucleosome assembly and immobilisation.  Equal amounts 
of assembled nucleosomes before (Input) and after (SN) incubation with 
streptavidin beads were run on 5% native PAGE gels and stained with 
ethidium bromide. The nucleosomal DNA is almost completely shifted into a 
single slower migrating species indicating correct assembly of nucleosomes. 
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The absence of bands in the supernatant after binding indicates successful 
immobilisation on the streptavidin matrix. Unmethylated and CpG-methylated 
601- and 603-DNA assemble with equal efficiencies.  Nucleosomes 
assembled from WT octamer are shown here as a representative example, all 
other nucleosomes were assembled with the same efficiency. (H) Functional 
test of the nucleosome affinity matrix. Immobilised modified nucleosomes 
were incubated with and without R10K8-labelled nuclear extract as indicated. 
After washing, modification of histones was detected by SDS-PAGE and 
immunoblot using antibodies against H3 tri-methyl lysine marks and an 
antibody recognising acetyl-lysines as indicated. No modification of 
unmodified nucleosomal histones can be detected with any of the antibodies. 
Therefore, we conclude that no modification by histone modifying enzymes or 
exchange of histones present in the extracts takes place. All three antibodies 
against methyl lysine marks show slight cross-reactivity. Equal loading was 
confirmed by Coomassie staining. This figure is an extended version of the 
experiment shown in Figure 1D. Similar results were obtained with the 
unlabelled R0K0-nuclear extract. 
 
Figure S2. Identification of Chromatin Modification-interacting Proteins 
by SNAP, related to Figure 2 
Results of SNAP performed with CpG-methylated 601-DNA (A), methyl-CpG 
601-DNA-containing WT nucleosomes (B), CpG-methylated 603-DNA (C), WT 
nucleosomes containing methyl-CpG 603-DNA (D), H3K4me3-modified 
nucleosomes containing unmethylated 601-DNA (E) or methyl-CpG 601-DNA 
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(F), and H3K27me3-modified nucleosomes containing unmethylated 601-DNA 
(G) or methyl-CpG 601-DNA (H) as indicated. Shown are the Log2-values of 
the SILAC ratios (ratio H/L) of each identified protein for the forward (X-axis) 
and the reverse (Y-axis) experiments. The identities of several interacting 
proteins are indicated. Subunits of the MBD2/NuRD-complex are labelled in 
orange. For values see Table S1. 
 
Figure S3. LRWD1 Interacts with the Origin Recognition Complex, 
related to Figure 4 
(A) Specificity control of the anti-LRWD1 antibody. Whole cell extracts of 
HeLaS3 cells over-expressing FLAG-tagged full length LRWD1 or the N-
terminal 274 amino acids of LRWD1 (LRWD1 ΔWD40) used for the 
immunisation were separated by SDS-PAGE and probed with an anti-FLAG 
and the anti-LRWD1 (2527) antibody. The immunoblots show that the anti-
LRWD1 antibody recognises full length LRWD1 and LRWD1 ΔWD40 as 
indicated on the right hand side. Note the high molecular weight signal in the 
FLAGLRWD1 sample which most likely represents poly-ubiquitylated forms of 
LRWD1 (see also below). The asterisk marks a cross-reactive band detected 
by the anti-LRWD1 antibody. (B) LRWD1 and Orc2 IF co-staining with HP1α 
in MCF7 cells following pre-extraction. The IFs show partial co-localisation of 
LRWD1 and Orc2 with HP1α at distinct nuclear foci. The rabbit anti-LRWD1 
antibody was used in conjunction with a mouse anti-HP1α antibody and a 
mouse anti-Orc2 antibody was used together with a rabbit anti-HP1α antibody 
as indicated. (C) LRWD1 and ORC co-immunoprecipitate. LRWD1 and Orc2 
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were immunoprecipitated from the HeLaS3 R10K8-labelled nuclear extract and 
interacting proteins were detected by immunoblot as indicated. LRWD1 was 
immunoprecipitated using anti-LRWD1 (A301-867A) and detected using anti-
LRWD1 (2527) antibodies. Anti-FLAG and anti-GFP antibodies were used as 
IgG negative controls. Asterisks mark bands derived from antibody heavy 
chains. (D) FLAG-tagged full length and truncated versions of LRWD1 were 
over-expressed in 293T cells and immunoprecipitated. 1 % of the input and 
10% of the IP were separated by SDS-PAGE and LRWD1 deletions were 
detected by immunoblot against the FLAG epitope. The positions of the 
LRWD1 deletions are marked. The asterisks mark bands derived from the 
anti-FLAG IP antibody. Note that deletions containing the WD40 repeats are 
expressed below the detection level of the anti-FLAG antibody in the 293T 
extracts but can be detected in the IP samples. This is probably due to 
proteasomal degradation in the cell since the anti-FLAG antibody detects a 
high molecular weight ladder which most likely represents poly-ubiquitylated 
forms of LRWD1 (marked by LRWD1-Ubn). This figure includes the complete 
anti-FLAG immunoblots for the input and the IP of the experiment shown in 
Figure 4C. 
 
Figure S4. Analysis of Fbxl11/KDM2A Isoforms Enriched on H3K9me3-
modified Nucleosomes, related to Figure 5 
(A) SILAC analysis of KDM2A peptides identified in the H3K9me3/601-
nucleosome pulldown.  The figure shows the sequences, position, and the 
SILAC ratios H/L of KDM2A-specific peptides identified by MS in two marked 
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gel slices. The peptides isolated from the gel slice of a molecular weight of 
approximately 150 kDa have an enrichment value of around 1.5. More 
peptides are isolated from the gel slice of a molecular weight of approximately 
60-75 kDa and these peptides display an enrichment value of around 3. (B) 
Position of the peptides identified in (A) within the KDM2A sequence. All 
peptides identified in the 60-75 kDa gel slice are derived form the C-terminal 
part of the protein corresponding to the short isoform KDM2ASF. (C) Binding of 
KDM2A isoforms to H3K9me3-modified nucleosomes. The R0K0-nuclear 
extract was incubated with immobilised modified nucleosomes as indicated. 
Binding of KDM2A was detected by SDS-PAGE and immunoblot using the 
central KDM2A antibody. The asterisk marks a cross-reactive band 
recognised by the KDM2A antibody. Equal loading was confirmed by 
Coomassie staining. Modification of nucleosomal histone H3 was verified by 
immunoblot against H3 tri-methyl lysine marks. All three antibodies show 
slight cross-reactivity with the other histone marks. The full length form of 
KDM2A binds only weakly whereas the short isoform KDM2ASF shows a 
significant enrichment on the H3K9me3-modified nucleosome confirming the 
results obtained by the SILAC analysis. (D) KDM2A was immunoprecipitated 
from the R0K0-nuclear extract in denaturing RIPA buffer using three different 
KDM2A-specific antibodies (N-terminal: Abcam ab31739; central: Bethyl 
Laboratories A301-475A; C-terminal: Bethyl Laboratories A301-476A). 
Immunoprecipitated isoforms were detected with the same antibodies as 
indicated. The N-terminal antibody immunoprecipitates KDM2A only weakly. 
The central antibody immunoprecipitates both the full length and the short 
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isoform (KDM2ASF) of KDM2A. The C-terminal antibody does not 
immunoprecipitate. Therefore, the central antibody was used in immunoblots 
and ChIP experiments throughout this study. The epitopes of the KDM2A 
antibodies are indicated by red bars in (B). The asterisk marks bands derived 
from the antibodies used for immunoprecipitation. (E) KDM2A does not bind 
methylated DNA. Streptavidin beads were saturated with unmodified or CpG-
methylated 601-DNA and incubated with whole cell extracts prepared from 
transiently transfected 293T cells over-expressing FLAG-tagged KDM2A. 
After washing, binding was detected by SDS-PAGE and immunoblot against 
the FLAG-tag. Equal loading was verified by SDS-PAGE and Coomassie 
staining for the streptavidin protein.  
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Supplemental Table Legends 
 
Table S1. SILAC Nucleosome Affinity Pulldowns, related to Figures 2 
and S2 
The table consists of 10 sheets containing the complete MS analysis defining 
all SILAC ratios H/L of all identified proteins in all pulldown reactions. Each 
SNAP experiment is presented as a separate sheet containing a list of all 
proteins identified with SILAC ratios in both, forward and reverse, 
experiments. Proteins are sorted in a descending order according to the ratio 
H/L in the forward experiment (enriched proteins at the top and excluded 
proteins at the bottom of the list). For each protein the Uniprot and ENSEMBL 
accession numbers, the number of unique peptides identified, and the 
sequence coverage are indicated. Significance B is a ratio and intensity based 
p value that indicates the probability that the respective protein is a significant 
outlier from the background population (Cox and Mann, 2008). The SILAC 
enrichment values (ratio H/L) for the forward and reverse experiments are 
colour coded according to the level of enrichment as indicated on the right 
hand side. Proteins bind the modified DNA or nucleosomes if they display a 
high ratio H/L (red) in the forward and a low ratio H/L (blue) in the reverse 
experiments. Proteins that are excluded from the modified DNA or 
nucleosomes display a low ratio H/L (blue) in the forward and a high ratio H/L 
(red) in the reverse experiments. False positive hits show high ratios H/L (red) 
and contaminants show low ratios H/L (blue) in both, the forward and reverse, 
experiments. 
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Table S2. Chromatin Modification-interacting Proteins Identified by 
SNAP, related to Figure 3 
The table summarises the SILAC ratios (ratio H/L) of proteins found to bind to 
DNA and nucleosomes in a modification-dependent manner. For each 
pulldown the SILAC ratios obtained in the forward and reverse pulldown 
experiments are listed. Proteins included in this list display an 
enrichment/exclusion of at least 1.5 fold in both directions in at least one of 
the pulldown experiments performed (see Table S1). Proteins are listed 
alphabetically according to their gene names. For each protein the Uniprot 
and ENSEMBL accession numbers, the number of unique peptides identified, 
and the sequence coverage are indicated. Protein domains as identified in 
Uniprot are listed on the right hand side. The SILAC enrichment values (ratio 
H/L) are colour coded according to the level of enrichment as indicated on the 
right hand side. Proteins are enriched on the modified DNA or nucleosomes if 
they display a high ratio H/L (red) in the forward and a low ratio H/L (blue) in 
the reverse experiments. Proteins that are excluded from the modified DNA or 
nucleosomes display a low ratio H/L (blue) in the forward and a high ratio H/L 
(red) in the reverse experiments. If proteins were not detected (n.d.) in 
particular experiments no value is assigned.  
 
 
 11 
Supplemental Experimental Procedures 
 
Plasmids 
The cDNAs for human core histone proteins were generated by RT-PCR from 
MCF7 total RNA and cloned into pET21b(+) (Novagen) for expression in E. 
coli. The expression construct for the tail-less H3.1Δ1-31T32C protein was 
generated by PCR from the H3.1 expression vector using a primer encoding a 
modified TEV-protease cleavage site (ENLYFQ↓C) directly 3ʼ of G33 of H3.1 
and cloned into a pET28a(+) vector (Novagen) containing an expression 
cassette for His6-tagged TEV-protease under the control of the AraC-PBAD-
promoter. pUC19 vectors containing 16 tandem repeats of either the 601 or 
the 603 nucleosome positioning sequence flanked by EcoRV and EcoRI sites 
were generated as described (Dyer et al., 2004). Constructs containing the 
601- and 603-sequences were kind gifts from Timothy Richmond and 
Jonathan Widom, respectively. Constructs for FLAG-tagged LRWD1 were 
generated by PCR from IMAGE clone 5170588 and cloned into a 
pcDNA5/FRT/TO-based expression vector. The expression construct for 
FLAG-tagged Fbxl11/KDM2A was a kind gift from Yi Zhang.  
 
Antibodies 
Antibodies for immunoblots directed against histone H3K4me3 (ab8580) and 
H3K9me3 (ab8898) were rabbit polyclonals obtained from Abcam as were 
rabbit anti-PHF8 (ab35471), rabbit anti-SUZ12 (ab12073), mouse anti-UHRF1 
(ab57083), and the N-terminal rabbit anti-KDM2A antibody (ab31739). The 
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central and C-terminal rabbit anti-KDM2A antibodies (A301-475A and A301-
476A) were from Bethyl Laboratories. Rabbit anti-H3K27 was from Millipore 
(07-449). Mouse monoclonal against acetyl-lysine Ac-K-103 (9681) was from 
Cell Signaling as was rabbit anti-HP1α (2616). Anti-Flag M2 monoclonal was 
from Sigma. Anti-His6-tag monoclonal H3 was from Santa Cruz (sc-8036). 
Mouse monoclonal anti-hOrc1 (clone PKS 40) and anti-hOrc2 (clone 920) 
were a kind gift from Bruce Stillman. Goat anti-Orc3 was from Abcam 
(ab9213). A rabbit anti-LRWD1 (2527) antibody was raised and affinity 
purified against the recombinantly expressed N-terminal 274 amino acids of 
human LRWD1 (LRWD ΔWD40).  
Antibodies for co-immunoprecipitation experiments were mouse monoclonal 
anti-Flag M2 (Sigma) and anti-hOrc2 (clone 920) and rabbit antibodies against 
GFP (A11122, Invitrogen) and LRWD1 (A301-867A, Bethyl). The rabbit anti-
LRWD1 (2527) antibody immunoprecipitates only weakly. 
Primary antibodies used for immunofluorescence staining were mouse 
monoclonal anti-hOrc2 (ab68348, Abcam), mouse monoclonal anti-HP1α (05-
689, Millipore; for LRWD1 co-staining), rabbit anti-LRWD1 (2527, this study) 
and rabbit anti-HP1α (2616, Cell Signaling; for Orc2 co-staining). The 
secondary donkey AF-488 anti–mouse IgG (green) and donkey AF-546 anti-
rabbit (red) antibodies were purchased from Molecular Probes. 
The rabbit antibodies used for the ChIP analysis were anti-GFP (A11122, 
Invitrogen), anti-KDM2A (A301-475A, Bethyl), anti-HP1α (2616, Cell 
Signaling), anti-H3 (ab1791, Abcam) and anti-H3K9me3 (ab8898, Abcam). 
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Primers for ChIP Analyses 
The sequences of the primers used for ChIP are: rDNA (H13): 5′-
ACCTGGCGCTAAACCATTCGT-3′ and 5′-GGACAAACCCTTGTGTCGAGG-
3′ (Tanaka et al., 2010); GAPDH: 5′-TCGACAGTCAGCCGCATCT-3′ and 5′-
CTAGCCTCCCGGGTTTCTCT-3′. 
 
siRNAs Used in This Study 
The siRNAs used were FlexiTube siRNAs from Qiagen: siOrc2-1: 
Hs_ORC2L_6; siOrc2-2: Hs_ORC2L_8; siLRWD1-1: Hs_DKFZp434K1815_6 
siLRWD1-2: Hs_DKFZp434K1815_7; siHP1α: pool of Qiagen 
Hs_CBX5_5,6,7 and 8 FlexiTube siRNAs. 
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Table 1. Proteins Enriched or Excluded by CpG-methylated DNA and Nucleosomes as Identified by SNAP 
Enrichment/Exclusion  
(Ratio H/L forward) 
601
me
-DNA 603
me
-DNA 601
me
-Nuc 603
me
-Nuc 
E
n
ri
c
h
e
d
 P
ro
te
in
s
 
Very Strong Enrichment 
(>10) 
ZBTB33 ZBTB33  ZHX2 
Strong Enrichment 
(5 - 10) 
ZHX1 ZHX1 
MBD2
2
 
HOMEZ 
 UHRF1 
Moderate Enrichment 
(2 - 5) 
ZBTB9 
ZHX2 
ZHX3 
MBD2
2
 
MTA2
2
 
CDK2AP1
2
 
GATAD2A
2
 
FOXA1 
CHD4
2 
ZNF295 
MTA3
2
 
HOMEZ 
MTA1
2
 
GATAD2B
2
 
MBD4 
ZHX2 
MTA2
2
 
GATAD2A
2
 
MTA3
2
 
ZHX3 
CDK2AP1
2
 
FOXA1 
CHD4
2 
GATAD2B
2
 
RFXANK
4
 
RFXAP
4
 
MTA1
2
 
PBX1 
RFX5
4
 
PKNOX1 
FIZ1 
TRIM28 
ZBTB40 
MeCP2 
PAX6 
MTERF 
MBD2
2
 
GATAD2A
2
 
MTA2
2
 
MBD2
2
 
MBD4 
ZBTB12 
CHD4
2
 
MeCP2 
GATAD2B
2
 
ZHX3 
ZHX1 
C14orf93 
RBBP4
2
 
RBBP7
2
 
MTERF 
PAX6 
LCOR 
Weak Enrichment 
(1.5 - 2) 
PAX9 
CHD3
2 
CUX1 
ZNF740* 
 
RBBP7
2 
POGZ 
KIAA1958 
UHRF1 
ZNF787 
MBD4 
CHD3
2
 
ZFHX3 
ZBTB9* 
NR2C1 
MAD2B  
MTA2
2
 
MBD4 
CHD4
2
 
GATAD2A
2
 
PPIB 
 
ACTR5 
ZBED5 
AURKA 
HOXC10 
JUNB  
E
x
c
lu
d
e
d
 P
ro
te
in
s
 
Weak Exclusion 
(0.5 - 0.67) 
 
 
ANKRD32 
 
Atherin* 
SKP1*
,1
 
RBBP5 
NUFIP1 
CBFB 
MSH3 
RBBP5 
 
Moderate Exclusion 
(0.2 - 0.5) 
RB1 
TFEB 
SIX4 
HES7 
ZFP161 
YAF2 
TIGD5 
ARID4B 
CXXC5 
SKP1
1
 
JRK 
USF2 
USF1 
FBXW11 
RAD1 
ZBTB2 
MLX 
BCORL1 
ZNF639 
SP3 
HES7 
TCOF1* 
TFDP1 
ATF1 
MLL 
SKP1
1
 
RECQL 
ONECUT2 
ZFP161 
TIGD1 
RB1 
E2F3 
CUX1 
EED
3
 
RUNX 
RNF2
1
 
RING1
1 
BANP 
PRDM11 
SUZ12
3
 
NAIF1 
MYC 
SUB1 
RMI1 
TOP3A 
RPA2
5
 
NAIF1 
RPA1
5
 
RPA3
5
 
KIAA1553 
TCF7L2 
RNF2
1
 
BCOR
1 
RING1
1
 
BANP* 
Strong Exclusion 
(0.1 - 0.2) 
ZBTB25 
PURB 
RPA1
5
 
RPA3*
,5
 
RPA2
5
 
MNT 
UBF1 
UBF2 
EED
3
 
SUZ12
3
 
VHL 
E2F4 
BCOR
1
 
FBXL10
1
 
FBXL11 
SUZ12
3
 
RPA3
5
 
SSBP1 
RPA2
5
 
RPA1
5
 
CGGBP1 
UBF2 
FBXL11 
PURA 
UBF1 
ZBTB2 
ZNF639 
RAD1 
HUS1 
PURB 
BCORL1 
OLA1 
MAX 
L3MBTL3 
BCOR
1
 
FBXL10
1
 
PCGF1
1
 
FBXL11 
SUB1 
FBXL10
1
 
Very Strong Exclusion 
(< 0.1) 
E2F1 
PCGF1
1
 
ZNF395 
TIMM8A 
KIAA1553 
bHLHB2 
CGGBP1 
GMEB2 
GTF3C2
6
 
BCOR
1
 
GTF3C4
6
 
FBXL10
1
 
PCGF1
1
 
GTF3C1
6
 
E2F1 
DEAF1 
GTF3C3
6
 
GTF3C6
6
 
GTF3C5
6
 
HIF1A 
CXXC5 
BCORL1* 
FBXL11 
Syntenin1 
ARNT 
HES7 
USF2 
bHLHB2 
USF1 
 
PCGF1
1
 
Atherin 
L3MBTL3 
FLYWCH1 
Syntenin1 
ZFP161 
Table 1 shows the proteins that were enriched or excluded by CpG-methylated DNA or nucleosomes compared to the respective unmodified species at least 
1.5-fold in both, the forward and reverse pulldown experiments. Proteins are grouped according to their ratio H/L in the forward experiments. Proteins marked 
by an asterisk* are just below the threshold. For the values of the SILAC ratios see Tables S1 and S2. Protein complex subunits: 
1
BCOR-complex, 
2
NuRD-
complex, 
3
PRC2-complex, 
4
Regulatory factor X, 
5
Replication factor A-complex, 
6
TFIIIC-complex. 
 
Table 1
Table 2. Nucleosome-binding Proteins Regulated by CpG- and Lysine-Methylation as Identified by SNAP  
Enrichment/Exclusion 
(Ratio H/L forward)  
H3K4me3/ 
601-Nuc 
H3K4me3/ 
601
me
-Nuc 
H3K9me3/ 
601-Nuc 
H3K9me3/ 
601
me
-Nuc 
H3K27me3/ 
601-Nuc 
H3K27me3/ 
601
me
-Nuc 
E
n
ri
c
h
e
d
 P
ro
te
in
s
 
Very Strong Enrichment 
(>10) 
Spindlin1 IWS1 
Spindlin1 
CBX5/HP1
UHRF1 
UHRF1   
Strong Enrichment 
(5 - 10) 
PHF8 
CHD1 
PHF8 CBX3/HP1 
CDYL2 
CBX5/HP1
Orc4
3
 
Orc2
3
 
Orc3
3
 
Orc5
3
 
LRWD1 
MeCP2 
  
Moderate Enrichment 
(2 - 5) 
DIDO1 
UBF1 
Sin3A
6
 
PAX6 
CHD1 
MeCP2 
MTERF 
MBD2
2
 
DIDO1 
Orc2
3
 
Orc4
3
 
MBD4 
LRWD1 
CDYL 
FBXL11 
UBF1 
Orc2
3 
Orc4
3
 
Orc5
3
 
Orc3
3
 
PAX6 
CBX3/HP1 
CDYL 
MTERF 
MBD2
2
 
Orc1
3
 
C17orf96 
LRWD1 
EED
4
 
Orc4
3
 
Orc5
3
 
SUZ12
4
 
Orc2
3 
Orc3
3
 
EZH2
4
 
MTF2 
CBX8 
LRWD1 
Orc2
3
 
Orc3
3
 
Orc4
3
 
Orc5
3
 
MeCP2 
CBX8 
UHRF1 
PAX6 
MTERF 
Orc1
3 
Weak Enrichment 
(1.5 - 2) 
SAP30
6
 
WDR82 
EMG1 
TAF9B 
PPIB 
VRK2 
HNRNPA1* 
HNRNPA2B1* 
ING4 
WDR61 
HNRNPA0* 
FLYWCH1 
BUB3 
FUBP3 
Orc5
3
 
LRWD1 
PPIB 
ING4 
TOX4 
MTA2
2
 
CHD4
2
 
ZSCAN21 
Orc3
3
 
NONO 
CDCA7L* 
WDR82* 
CHD1 
SUZ12
4
 
EED
4
 
PPIB 
NONO 
MTF2 
SUB1 
MTA2
2
 
MBD4 
ZSCAN21 
CHD4
2 
NSD3 
 
PPIB 
 
CDCA7L 
BMI1 
PPIB 
MTA2
2 
MBD4* 
E
x
c
lu
d
e
d
 P
ro
te
in
s
 
Weak Exclusion 
(0.5 - 0.67) 
 
 
SKP1
1
 
RCOR1 
 
 SKP1
1
 
CREB1 
 
 HCFC1 
PHF14 
SKP1
1
 
Moderate Exclusion 
(0.2 - 0.5) 
HMG20A 
HMG20B 
MTF2* 
RING1
1
 
SUB1 
HMG20B 
NAIF 
MYC 
IMP4 RCOR1 
BANP 
RING1
1
 
SUB1 
EED
4
 
TIGD5 
RNF2
1
 
MYC 
NAIF1 
ARNT 
TCF7L2 
HES7 
 SPTH16
7
 
SSRP1
7
 
TCF7L2 
BANP* 
PRDM11 
NAIF1 
RPA1
5
 
BANP* 
SUB1 
 
Strong Exclusion 
(0.1 - 0.2) 
PHF14 FBXL10
1
 
PHF14 
BCOR
1
 
PCGF1
1
 
 MAX 
CXXC5 
L3MBTL3 
FBXL10
1
 
BCOR
1
 
 RPA2
5
 
BCOR
1
 
MYC 
FBXL10
1
 
PCGF1
1
 
MAX 
Very Strong Exclusion 
(< 0.1) 
 L3MBTL3 
ARNT 
FBXL11 
Syntenin1 
Atherin 
USF2 
USF1 
HIF1A* 
bHLHB2 
 PCGF1
1
 
HIF1A 
Syntenin1 
FBXL11 
Atherin 
USF1 
USF2 
bHLHB2 
 L3MBTL3 
HES7 
Syntenin1 
HIF1A 
Atherin 
ARNT 
FBXL11 
USF1 
USF2 
bHLHB2 
Table 2 shows the proteins that were enriched or excluded by modified nucleosomes compared to unmodified nucleosomes at least 1.5-fold in both, the 
forward and reverse pulldown experiments. Proteins are grouped according to their ratio H/L in the forward experiments. Proteins marked by an asterisk* are 
just below the threshold. For the values of the SILAC ratios see Tables S1 and S2. Protein complex subunits: 
1
BCOR-complex, 
2
NuRD-complex, 
3
ORC 
complex, 
4
PRC2-complex, 
5
Replication factor A-complex, 
6
Sin3A-complex, 
7
FACT. IWS should be treated with caution since it was found as a false positive 
outlier in the 601
me
-Nuc pulldown. Fbxl11/KDM2A is highlighted in bold. 
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